Skip to main content
OpenTrials

Clinical trial condition

Refractory Plasma Cell Myeloma

Explore clinical trials studying Refractory Plasma Cell Myeloma. Study availability and eligibility vary by location and protocol.

55 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Refractory Plasma Cell Myeloma trial results

Completed

Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma

NCT01605032

Conditions
Blood Protein Disorders, Cardiovascular Diseases, DS Stage I Plasma Cell Myeloma, +16 more
Locations
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • NYU Cancer Institute New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Albert Einstein College of Medicine The Bronx, New York, United States
View Trial Details
Completed

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

NCT00789776

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +49 more
Locations
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States
  • Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00105001

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, +173 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
View Trial Details

Related conditions